Gregory T. Went

Gregory T. Went

Chief Executive Officer at
Dextera Biosciences, Inc.
62 year
Health Technology
Consumer Services
Commercial Services

Profile

Gregory T.
Went
was the founder of CuraGen Corp., founded in 1992, where the title held was Director & Executive Vice President in 1999.
Dr. Went was the founder of Adamas Pharmaceuticals LLC, founded in 2000, holding the titles of Chairman, President & Chief Executive Officer.
Went was the founder of Tethys Bioscience, Inc., founded in 2002, with the title of Director from 2002 to 2009.
The current job is Chairman & Chief Executive Officer at Dextera Biosciences, Inc. since 2021, with employment starting in 2020.
Former jobs include Chairman & Chief Executive Officer at Neuromolecular Pharmaceuticals, Inc., Director at ParAllele BioScience, Inc., Director at Angelica Therapeutics, Inc., Managing Director at Halteres Associates LLC, and Advisor at Presidio Partners.
Education includes an undergraduate degree from Carnegie Mellon University in 1985 and a doctorate from the University of California, Berkeley in 1990.

Gregory T. Went active positions

CompaniesPositionStart
Chief Executive Officer 2021-07-31

Former positions of Gregory T. Went

CompaniesPositionEnd
ADAMAS PHARMACEUTICALS, INC. Chief Executive Officer 2019-09-10
Founder 1998-12-31
Director/Board Member -
Chairman -
Corporate Officer/Principal -
See the detail of Gregory T. Went's experience

Training of Gregory T. Went

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

83

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Angelica Therapeutics, Inc.

Health Services

  1. Stock Market
  2. Insiders
  3. Gregory T. Went